NCT05750043View on ClinicalTrials.gov

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan

CompletedOBSERVATIONAL
Enrollment

17,000

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

February 19, 2023

Conditions
OnchocerciasisEpilepsy
Interventions
DRUG

bi-annual CDTI

"bi-annual community directed treatment with ivermectin (CDTI) and community-based slash and clear vector control intervention"

Trial Locations (1)

140

Amref Health Africa, Juba

All Listed Sponsors
collaborator

Amref Health Africa

OTHER

lead

Universiteit Antwerpen

OTHER

NCT05750043 - Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan | Biotech Hunter | Biotech Hunter